Pharmacogenomics of oral antidiabetic medications: current data and pharmacoepigenomic perspective
出版年份 2011 全文链接
标题
Pharmacogenomics of oral antidiabetic medications: current data and pharmacoepigenomic perspective
作者
关键词
-
出版物
PHARMACOGENOMICS
Volume 12, Issue 8, Pages 1161-1191
出版商
Future Medicine Ltd
发表日期
2011-08-15
DOI
10.2217/pgs.11.65
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Statement by an American Association of Clinical Endocrinologists/American College of Endocrinology Consensus Panel on Type 2 Diabetes Mellitus: An Algorithm for Glycemic Control
- (2013) Helena Rodbard et al. Endocrine Practice
- Deregulation of microRNA-503 Contributes to Diabetes Mellitus–Induced Impairment of Endothelial Function and Reparative Angiogenesis After Limb Ischemia
- (2011) Andrea Caporali et al. CIRCULATION
- Impact of clinical factors and CYP2C9 variants for the risk of severe sulfonylurea-induced hypoglycemia
- (2011) Andreas Holstein et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Sirt1 and mir-9 expression is regulated during glucose-stimulated insulin secretion in pancreatic β-islets
- (2011) Deepti Ramachandran et al. FEBS Journal
- Type 2 Diabetes Mellitus: Managing Hemoglobin A1c and Beyond
- (2011) Grant C. Fowler et al. SOUTHERN MEDICAL JOURNAL
- Significance of serum microRNAs in pre-diabetes and newly diagnosed type 2 diabetes: a clinical study
- (2010) Lei Kong et al. ACTA DIABETOLOGICA
- The TCF7L2 Diabetes Risk Variant is Associated with HbA1C Levels: a Genome-Wide Association Meta-Analysis
- (2010) Christopher S. Franklin et al. ANNALS OF HUMAN GENETICS
- SLCO1B1 Polymorphism and Oral Antidiabetic Drugs
- (2010) Annikka Kalliokoski et al. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
- Pharmacogenetic biomarkers as tools for improved drug therapy; emphasis on the cytochrome P450 system
- (2010) Magnus Ingelman-Sundberg et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Insulin resistance at the crossroads of metabolic syndrome: Systemic analysis using microarrays
- (2010) Eunjung Kim Biotechnology Journal
- MicroRNA signature of the human developing pancreas
- (2010) Samuel Rosero et al. BMC GENOMICS
- Prioritizing genes for follow-up from genome wide association studies using information on gene expression in tissues relevant for type 2 diabetes mellitus
- (2010) Hemang Parikh et al. BMC Medical Genomics
- Epigenetics
- (2010) Mark E. Cooper et al. CIRCULATION RESEARCH
- Oxidative Stress and Diabetic Complications
- (2010) Ferdinando Giacco et al. CIRCULATION RESEARCH
- Plasma MicroRNA Profiling Reveals Loss of Endothelial MiR-126 and Other MicroRNAs in Type 2 Diabetes
- (2010) Anna Zampetaki et al. CIRCULATION RESEARCH
- Common Variants in 40 Genes Assessed for Diabetes Incidence and Response to Metformin and Lifestyle Intervention in the Diabetes Prevention Program
- (2010) K. A. Jablonski et al. DIABETES
- Effect of sulphonylurea treatment on glycaemic control is related to TCF7L2 genotype in patients with type 2 diabetes
- (2010) Z. Schroner et al. DIABETES OBESITY & METABOLISM
- Genetic variants of the insulin receptor substrate-1 are influencing the therapeutic efficacy of oral antidiabetics
- (2010) A. Seeringer et al. DIABETES OBESITY & METABOLISM
- MicroRNA-15a positively regulates insulin synthesis by inhibiting uncoupling protein-2 expression
- (2010) Liang-Liang Sun et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Nucleosome dynamics and epigenetic stability
- (2010) Philipp Korber et al. Essays in Biochemistry
- Endothelial Dysfunction, Inflammation, and Apoptosis in Diabetes Mellitus
- (2010) Inge A. M. van den Oever et al. MEDIATORS OF INFLAMMATION
- Common polymorphisms of the peroxisome proliferator-activated receptor–γ (Pro12Ala) and peroxisome proliferator-activated receptor–γ coactivator–1 (Gly482Ser) and the response to pioglitazone in Chinese patients with type 2 diabetes mellitus
- (2010) Ming-Chia Hsieh et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Common variants near ATM are associated with glycemic response to metformin in type 2 diabetes
- (2010) Kaixin Zhou et al. NATURE GENETICS
- A map of open chromatin in human pancreatic islets
- (2010) Kyle J Gaulton et al. NATURE GENETICS
- Common variation in the NOS1AP gene is associated with reduced glucose-lowering effect and with increased mortality in users of sulfonylurea
- (2010) Matthijs L. Becker et al. Pharmacogenetics and Genomics
- OCT2 polymorphisms and in-vivo renal functional consequence: studies with metformin and cimetidine
- (2010) Zhi-Jun Wang et al. Pharmacogenetics and Genomics
- ABCC8polymorphism (Ser1369Ala): influence on severe hypoglycemia due to sulfonylureas
- (2010) Ryosuke Sato et al. PHARMACOGENOMICS
- Effect ofCYP2C9polymorphisms on prescribed dose and time-to-stable dose of sulfonylureas in primary care patients with Type 2 diabetes mellitus
- (2010) Jesse J Swen et al. PHARMACOGENOMICS
- MicroRNAs and pharmacogenomics
- (2010) Noam Shomron PHARMACOGENOMICS
- The past, present and future of pharmacoepigenomics
- (2010) Magnus Ingelman-Sundberg et al. PHARMACOGENOMICS
- Personalized Prognosis and Diagnosis of Type 2 Diabetes – Vision or Fiction?
- (2010) Günter Müller PHARMACOLOGY
- Investigation of Type 2 Diabetes Risk Alleles Support CDKN2A/B, CDKAL1, and TCF7L2 As Susceptibility Genes in a Han Chinese Cohort
- (2010) Jie Wen et al. PLoS One
- High Glucose Suppresses Human Islet Insulin Biosynthesis by Inducing miR-133a Leading to Decreased Polypyrimidine Tract Binding Protein-Expression
- (2010) Rikard G. Fred et al. PLoS One
- RNAi and small interfering RNAs in human disease therapeutic applications
- (2010) Monica R. Lares et al. TRENDS IN BIOTECHNOLOGY
- The miR-30 family microRNAs confer epithelial phenotype to human pancreatic cells
- (2010) Mugdha V. Joglekar et al. Islets
- A Brief Review on the Mechanisms of miRNA Regulation
- (2010) Yimei Cai et al. GENOMICS PROTEOMICS & BIOINFORMATICS
- Human CYP2E1 is regulated by miR-378
- (2009) Takuya Mohri et al. BIOCHEMICAL PHARMACOLOGY
- Epigenetic control of gene expression
- (2009) Tomas J. Ekström BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- The Effects of Genetic Polymorphisms in the Organic Cation Transporters OCT1, OCT2, and OCT3 on the Renal Clearance of Metformin
- (2009) M V Tzvetkov et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Loss-of-Function CYP2C9 Variants Improve Therapeutic Response to Sulfonylureas in Type 2 Diabetes: A Go-DARTS Study
- (2009) K Zhou et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Pharmacogenetics in diabetes
- (2009) Ewan R. Pearson Current Diabetes Reports
- Genome-wide association studies in type 2 diabetes
- (2009) Mark I. McCarthy et al. Current Diabetes Reports
- Oral Antidiabetic Agents: Anti-Atherosclerotic Properties Beyond Glucose Lowering?
- (2009) N. Papanas et al. CURRENT PHARMACEUTICAL DESIGN
- Coexpression of the Type 2 Diabetes Susceptibility Gene Variants KCNJ11 E23K and ABCC8 S1369A Alter the ATP and Sulfonylurea Sensitivities of the ATP-Sensitive K+ Channel
- (2009) K. S.C. Hamming et al. DIABETES
- Genetic Variation in the Multidrug and Toxin Extrusion 1 Transporter Protein Influences the Glucose-Lowering Effect of Metformin in Patients With Diabetes: A Preliminary Study
- (2009) M. L. Becker et al. DIABETES
- Confirmation of Multiple Risk Loci and Genetic Impacts by a Genome-Wide Association Study of Type 2 Diabetes in the Japanese Population
- (2009) F. Takeuchi et al. DIABETES
- MicroRNAs Induced During Adipogenesis that Accelerate Fat Cell Development Are Downregulated in Obesity
- (2009) H. Xie et al. DIABETES
- Metformin - the gold standard in type 2 diabetes: what does the evidence tell us?
- (2009) E. Bosi DIABETES OBESITY & METABOLISM
- A Pilot Study Suggests that the G/G Genotype of Resistin Single Nucleotide Polymorphism at -420 May Be an Independent Predictor of a Reduction in Fasting Plasma Glucose and Insulin Resistance by Pioglitazone in Type 2 Diabetes
- (2009) Hideichi MAKINO et al. ENDOCRINE JOURNAL
- The effects of CYP2C9 and CYP2C19 genetic polymorphisms on the pharmacokinetics and pharmacodynamics of glipizide in Chinese subjects
- (2009) Bo Tan et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Oral antidiabetic drug metabolism: pharmacogenomics and drug interactions
- (2009) Andreas Holstein et al. Expert Opinion on Drug Metabolism & Toxicology
- The E23K Variant ofKCNJ11and the Risk for Severe Sulfonylurea-induced Hypoglycemia in Patients with Type 2 Diabetes
- (2009) A. Holstein et al. HORMONE AND METABOLIC RESEARCH
- Epigenetic control
- (2009) Geneviève P. Delcuve et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Epigenetics: Connecting Environment and Genotype to Phenotype and Disease
- (2009) S.P. Barros et al. JOURNAL OF DENTAL RESEARCH
- Thiazolidinediones and clinical outcomes in type 2 diabetes
- (2009) Ravi Retnakaran et al. LANCET
- Epigenetic side-effects of common pharmaceuticals: A potential new field in medicine and pharmacology
- (2009) Antonei B. Csoka et al. MEDICAL HYPOTHESES
- Epigenetic and microRNA-mediated regulation in diabetes
- (2009) P. Muhonen et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Effect of genetic variation in the organic cation transporter 2 on the renal elimination of metformin
- (2009) Ying Chen et al. Pharmacogenetics and Genomics
- Interaction between polymorphisms in the OCT1 and MATE1 transporter and metformin response
- (2009) Matthijs L. Becker et al. Pharmacogenetics and Genomics
- Epigenetic and microRNA-dependent control of cytochrome P450 expression: a gap between DNA and protein
- (2009) Alvin Gomez et al. PHARMACOGENOMICS
- MicroRNA polymorphisms: the future of pharmacogenomics, molecular epidemiology and individualized medicine
- (2009) Prasun J Mishra et al. PHARMACOGENOMICS
- Presence ofCYP2C9*3allele increases risk for hypoglycemia in Type 2 diabetic patients treated with sulfonylureas
- (2009) Georgia Ragia et al. PHARMACOGENOMICS
- Genetic variation in the organic cation transporter 1 is associated with metformin response in patients with diabetes mellitus
- (2009) M L Becker et al. PHARMACOGENOMICS JOURNAL
- miR-375 maintains normal pancreatic - and -cell mass
- (2009) M. N. Poy et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Increased sensitivity for troglitazone-induced cytotoxicity using a human in vitro co-culture model
- (2009) Ylva Edling et al. TOXICOLOGY IN VITRO
- Genetic variations in the pancreatic ATP-sensitive potassium channel, β-cell dysfunction, and susceptibility to type 2 diabetes
- (2008) D. A. Chistiakov et al. ACTA DIABETOLOGICA
- Association ofKCNJ11andABCC8genetic polymorphisms with response to repaglinide in Chinese diabetic patients1
- (2008) Ya-yi HE et al. ACTA PHARMACOLOGICA SINICA
- The cell biology of DNA methylation in mammals
- (2008) Egor Prokhortchouk et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- The effect ofSLCO1B1polymorphism on repaglinide pharmacokinetics persists over a wide dose range
- (2008) Annikka Kalliokoski et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Role of Advanced Glycation End Products (AGEs) and Oxidative Stress in Diabetic Retinopathy
- (2008) Sho-ichi Yamagishi et al. CURRENT PHARMACEUTICAL DESIGN
- Interaction of Oral Antidiabetic Drugs With Hepatic Uptake Transporters: Focus on Organic Anion Transporting Polypeptides and Organic Cation Transporter 1
- (2008) I. Bachmakov et al. DIABETES
- Ser1369Ala Variant in Sulfonylurea Receptor Gene ABCC8 Is Associated With Antidiabetic Efficacy of Gliclazide in Chinese Type 2 Diabetic Patients
- (2008) Y. Feng et al. DIABETES CARE
- Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy: A consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes
- (2008) D. M. Nathan et al. DIABETES CARE
- The influence of adiponectin gene polymorphism on the pioglitazone response in the Chinese with type 2 diabetes
- (2008) DIABETES OBESITY & METABOLISM
- Epigenetic regulation of PPARGC1A in human type 2 diabetic islets and effect on insulin secretion
- (2008) C. Ling et al. DIABETOLOGIA
- Interindividual variability in oral antidiabetic drug disposition and response: the role of drug transporter polymorphisms
- (2008) Michael A Pacanowski et al. Expert Opinion on Drug Metabolism & Toxicology
- MicroRNA miR-7 is preferentially expressed in endocrine cells of the developing and adult human pancreas
- (2008) Mayrin Correa-Medina et al. GENE EXPRESSION PATTERNS
- DNA methylomes, histone codes and miRNAs: Tying it all together
- (2008) Sònia Guil et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Different Effects ofSLCO1B1Polymorphism on the Pharmacokinetics and Pharmacodynamics of Repaglinide and Nateglinide
- (2008) Annikka Kalliokoski et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Effect of the Pro12Ala polymorphism of the PPARγ2 gene on response to pioglitazone treatment in menopausal women
- (2008) Mónica Ramírez-Salazar et al. MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY
- Minireview: The Wnt Signaling Pathway Effector TCF7L2 and Type 2 Diabetes Mellitus
- (2008) Tianru Jin et al. MOLECULAR ENDOCRINOLOGY
- LPIN1 genetic variation is associated with rosiglitazone response in type 2 diabetic patients
- (2008) Eun Seok Kang et al. MOLECULAR GENETICS AND METABOLISM
- Organic cation transporters
- (2008) G. Ciarimboli XENOBIOTICA
- No significant effect ofSLCO1B1polymorphism on the pharmacokinetics of rosiglitazone and pioglitazone
- (2007) Annikka Kalliokoski et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation